Lipid A on the Gram-negative outer membrane (OM) is synthesized in the cytoplasm by the Lpx pathway and translocated to the OM by the Lpt pathway. Some Acinetobacter baumannii strains can tolerate the complete loss of lipopolysaccharide (LPS) resulting from the inactivation of early LPS pathway genes such as lpxC. Here, we characterized a mutant deleted for lptD, which encodes an OM protein that mediates the final translocation of fully synthesized LPS to the OM. Cells lacking lptD had a growth defect comparable to that of an lpxC deletion mutant under the growth conditions tested but were more sensitive to hydrophobic antibiotics, revealing a more significant impact on cell permeability from impaired LPS translocation than from the loss of LPS synthesis. Consistent with this, ATP leakage and N-phenyl-1-naphthylamine (NPN) fluorescence assays indicated a more severe impact of lptD deletion than of lpxC deletion on inner and outer membrane permeability, respectively. Targeted 
I
n most Gram-negative bacteria, many of the proteins responsible for lipopolysaccharide (LPS) synthesis and transport are essential, making them potential targets for antibacterial drug development. In particular, the nine conserved Lpx enzymes are considered promising for the development of novel antibiotics, since (3-deoxy-D-manno-oct-2-ulosonic acid) 2 -lipid A (Kdo 2 -lipid A) is the minimal LPS structure that supports a functional outer membrane (OM) and cell viability for most Gram-negative bacteria (1, 2) . Indeed, the optimization of LpxC inhibitors has been an ongoing effort in antimicrobial research for over 2 decades, which has yielded compounds with impressive antibacterial activity against Gram-negative organisms such as Pseudomonas aeruginosa (1, (3) (4) (5) (6) (7) (8) (9) . The identification of RJPXD33, an antimicrobial peptide that inhibits both Escherichia coli LpxA and LpxD, and a recently identified LpxH inhibitor suggests that other LPS biosynthetic steps could also be successfully targeted (10) (11) (12) . POL7001, a peptidomimetic antibiotic that inhibits LptD, the final essential step of the LPS transport (Lpt) system, has potent and specific antibacterial activity against P. aeruginosa, which, importantly, indicates that the LPS transport and OM assembly machinery may be attractive targets for antibacterial discovery (13) (14) (15) .
Acinetobacter baumannii is an emerging opportunistic bacterial pathogen of increasing concern due to multidrug resistance (16) . A. baumannii is noted for its ability to develop resistance against most conventional antibiotics through mechanisms such as the upregulation of efflux pumps and horizontal transfer of resistance genes (17) (18) (19) . Because of this, clinical resistance is becoming a serious issue for this organism (as well as for other Gram-negative pathogens), often necessitating the use of antibiotics of last resort, such as polymyxins (19, 20) . Understanding resistance to polymyxins, which are cationic and utilize LPS to gain access to cells, has therefore become a focus of renewed in-terest (19) . Alteration of the charge status of LPS, for example, by 4-amino-4-deoxy-L-arabinose modification, is one well-studied mechanism of resistance (21) . More recently, it was discovered that resistance to colistin in A. baumannii ATCC 19606 could be mediated by the complete loss of LPS, in turn revealing that LPS is not essential in this organism, at least under typical in vitro growth conditions (22) (23) (24) . This observation extended data from previous reports that LPS is not essential in certain other Gram-negative organisms (25) (26) (27) . In A. baumannii ATCC 19606, genetic disruption of the initiating LPS biosynthesis gene lpxA, lpxC, or lpxD caused a complete loss of LPS and, correspondingly, colistin resistance (22) . Subsequent characterization of an lpxA mutant demonstrated that despite the lack of any measurable LPS, this strain could still generate a distinct outer membrane; however, the exact nature of this membrane remains to be determined (22) . The loss of LPS was accompanied by decreased in vitro growth rates, antibiotic sensitivity, and attenuated virulence (22, 24, 61) . The identification of A. baumannii strains that are able to grow in the absence of LPS provides new avenues to dissect the overall biosynthetic, assembly, and transport elements of this important pathway.
Of particular interest, mutants defective in downstream LPS biosynthesis steps (e.g., in the lpxH or lpxB gene), or in genes in the Lpt LPS transport pathway, were apparently not identified in colistin resistance selection experiments (22) . This suggests that the loss of these steps does not mediate colistin resistance and/or that they may be essential for viability even when biosynthesis of LPS per se is not. It has been speculated that inhibition of certain steps of LPS biosynthesis leads to the toxic accumulation of pathway intermediates that may disrupt inner membrane (IM) or OM function/integrity, the severity of which could vary from strain to strain (28) . For example, it was suggested that an advantage of LpxD inhibition over LpxC inhibition is the potential for the intracellular accumulation of an LpxD substrate, UDP-3-O-(R-3-OH-C 14 )-GlcN, a detergent-like molecule that could enhance cell killing (29) . Consistent with this, in A. baumannii ATCC 19606, the inactivation of lpxD was shown to have a greater impact on cell growth than the loss of lpxA or lpxC (24) .
The importance for bacteria to balance LPS and fatty acid biosynthesis to maintain envelope function and integrity has long been recognized in Escherichia coli (30) . Correspondingly, in response to sublethal LpxC inhibition, reduced activity of FabZ, involved in the dehydration of R-3-hydroxymyristoyl-acyl carrier protein (R-3-hydroxymyristoyl-ACP) in fatty acid biosynthesis, was shown to be critical for rebalancing fatty acid and lipid A homeostasis to produce E. coli with intact membrane integrity (31) . Likewise, in an E. coli conditional lptFG mutant, lethality was suppressed by loss-of-function mutations in genes important for fatty acid biosynthesis, including accD (acetyl coenzyme A [acetylCoA] carboxylase) and fabH (32) . Mutational loss of fabH reduced the rate of growth and cell size, which engendered lower rates of cell envelope growth, thereby restoring the balance of LPS assembly and envelope biogenesis (32) . Given the tightly controlled balancing of LPS and phospholipid biosynthesis in a variety of Gram-negative species, it is currently unknown how organisms such as A. baumannii ATCC 19606 and Neisseria meningitidis can survive without LPS (22, 33) .
In this report, we demonstrate that LptD, presumed to mediate the final transport of LPS to the OM, is nonessential in A. baumannii ATCC 19606. However, the loss of LptD compromised cell envelope integrity more than did the loss of LPS biosynthesis, implicating LPS intermediate accumulation and/or mislocalization in the disruption of membrane integrity.
(Portions of this work were presented in a poster at the 115th General Meeting of the American Society for Microbiology, 30 May to 2 June 2015 [62] .)
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in this study are described in Table S3 in the supplemental material. The growth media used were tryptic soy broth (TSB) (17.0 g/liter pancreatic digest of casein, 3.0 g/liter peptic digest of soy bean meal, 2.5 g/liter dextrose, 5.0 g/liter sodium chloride, 2.5 g/liter dipotassium hydrogen phosphate) and Mueller-Hinton II broth (MHIIB) (cation adjusted) (3.0 g/liter beef extract, 17.5 g/liter acid hydrolysate of casein, 1.5 g/liter starch, 20 to 25 mg/liter calcium, 10 to 12.5 mg/liter magnesium). To monitor growth, cells from frozen stocks were streaked onto tryptic soy agar (TSA) plates and incubated overnight (O/N) at 37°C. Cells were then inoculated into 5 ml TSB, incubated again O/N at 37°C at 220 rpm, and diluted to an optical density at 600 nm (OD 600 ) of 0.01. For each strain, an inoculum of 100 l was added to the wells of a 96-well plate, the plate was incubated at 37°C, and the OD 600 was measured every 60 min by using a SpectraMax instrument with Softmax Pro software. Additionally, to ensure that OD 600 values represented values for viable cells, after 24 h of incubation, alamarBlue cell viability reagent (Invitrogen) at 10% (vol/vol) was added to the wells, and resazurin (blue and nonfluorescent)-to-resorufin (pink and highly fluorescent) conversion was monitored (34) . To determine the effect of test compounds on growth rates, compounds were dissolved in dimethyl sulfoxide (DMSO) at 100 times the final assay concentration, and 1 l (1% final DMSO) was added to the well prior to the addition of the test inoculum. Cerulenin was purchased from Sigma, and CHIR-090 was described previously (35) . Where specified, growth in flask cultures was also assessed. Briefly, cells from frozen stocks were streaked for isolation onto TSA plates and incubated O/N at 37°C. The cells were then inoculated into fresh TSB and incubated again O/N at 37°C at 220 rpm. The cultures grown overnight were then diluted to an OD 600 of 0.01 in 50 ml of TSB in 250-ml Erlenmeyer flasks and incubated at 37°C with shaking at 220 rpm. The OD 600 was monitored every hour. Individual experiments were done in triplicate and repeated twice.
To monitor growth on plates, cells taken from 15% frozen glycerol stocks were streaked for isolation onto TSA plates and incubated O/N at 37°C. Colonies were then inoculated into 5 ml of TSB in a 50-ml conical tube and incubated O/N at 37°C at 220 rpm. The cultures grown overnight were diluted to an OD 600 of 0.1, 5 l was spread evenly onto TSA plates, and the plates were incubated O/N at 37°C before being photographed.
Determination of antibiotic MICs. Drug concentrations from 100ϫ stocks were prepared in 2-fold serial dilutions by adding 1 l of drug to wells 1 to 10 of a standard 96-well plate, with well 11 as the DMSO vehicle control and well 12 as a sterility control. Azithromycin, fusidic acid, novobiocin, polymyxin B, and rifampin were purchased from Sigma. Cell suspensions for susceptibility testing were prepared by using the BBL Prompt system according to the manufacturer's instructions. This provides cell suspensions in saline of ϳ1 ϫ 10 8 CFU/ml, equivalent to a 0.5 McFarland turbidity standard. The suspensions were then diluted 100-fold to 1 ϫ 10 6 CFU/ml in MHIIB, and 50 l of this inoculum was then added to 50 l of medium for a desired final density of 5.5 ϫ 10 5 CFU/ml in MHIIB. For fusidic acid, polymyxin B, and rifampin MIC determinations using complemented strains, the medium was supplemented with 10 g/ml of gentamicin (Sigma). (36) . For the creation of the lpxC::Km r mutant, a slight modification of this transformation protocol was employed as follows. A culture of A. baumannii ATCC 19606 was grown overnight in TSB and subcultured at a dilution of 1:20 into fresh TSB. The culture was then grown to an OD 600 of 0.8 and incubated on ice for 10 min. Cells were pelleted by centrifugation and then washed three times with 10% (vol/vol) glycerol and resuspended in 500 l of 10% (vol/vol) glycerol. An aliquot of 100 l of the cell suspension was mixed with 20 l of the lpxC::Km r disruption cassette fragment (0.5 g/ml), and the mixture was placed into a prechilled sterile electroporation cuvette (1-mm electrode gap; Bio-Rad) and immediately pulsed by using the Bio-Rad Gene Pulser (1.8 kV, 200 W, and 25 F). A 1-ml aliquot of TSB was added to the cuvette, and the mixture was transferred to a 15-ml Falcon centrifuge tube (catalog number 352057; Becton Dickinson) and incubated at 37°C at 220 rpm for 1 h. For both mutants, following transformation, cells were spread onto 10 TSA plates containing KAN (20 g/ml) and incubated at 35°C for up to 3 days. KAN-resistant colonies were transferred into a fresh 15-ml Falcon centrifuge tube containing TSB-KAN (20 g/ml) and incubated overnight at 37°C with shaking at 220 rpm. The resulting cultures were diluted in 10% (vol/vol) glycerol and stored at Ϫ80°C. Illumina full-genome sequencing of several clones was conducted to identify lpxC::Km r and lptD:: Km r mutants (designated NB48062-LMD0007 and NB48062-TMT0028, respectively) that were devoid of additional sequence polymorphisms for use in this study. It should be noted that during initial attempts to inactivate lpxC, LB medium was used. Mutants displayed poor growth on LB and MHIIB, growing in only heavily streaked areas, with a lack of individual colonies. In contrast, when the lpxC::Km r deletion strain was streaked onto TSA plates, individual colonies were obtained. Furthermore, CFU recovery from transformed cells on TSA was much better than that on LB or MHIIB. Therefore, the more growth-permissive TSA was used throughout genetic manipulations and for routine propagation as described above, unless otherwise indicated.
Complementation of the lpxC::Km r and lptD::Km r mutants. Oligonucleotide primers used are listed in Table S3 in the supplemental material. To complement the lpxC::Km r and lptD::Km r mutants, the coding sequences of lpxC and lptD with their putative promoter sequences were cloned into pNOV18 by using a GeneArt Seamless Cloning and Assembly kit (Life Technologies). The resulting plasmids (pNOV18-lpxC and pNOV18-lptD) were electroporated into their respective mutants by using the same procedures as those described above, except for a harvesting OD 600 of 0.5. Cells were then incubated at 37°C at 220 rpm for 2 h and selected on LB plates containing 50 g/ml gentamicin.
LPS visualization and quantification. A. baumannii cells were inoculated into 5 ml of TSB in a 50-ml conical tubes and incubated O/N at 37°C at 220 rpm. The following day, the culture was diluted to an OD 600 of 0.01 in fresh TSB and incubated at 37°C at 220 rpm until an OD 600 of 0.5 was reached. Total LPS from 2 ml of cell culture was isolated and stained by using Pro-Q Emerald 300 lipopolysaccharide gel stain (Invitrogen) after SDS-PAGE, as previously described (37) . The lipid A-core band was visualized by using the Bio-Rad ChemiDoc XRS ϩ system with Image Lab 3.0 software (Qdots 525). To ensure equal loading, gels were also stained with krypton protein stain according to the manufacturer's instructions (Thermo Scientific).
Membrane permeability assays. Cells were grown in 25 ml of TSB starting at an OD 600 of 0.01 in 50-ml conical tubes at 37°C with shaking at 220 rpm to an OD 600 of 0.5 and harvested by centrifugation at 8,000 ϫ g for 10 min. The pelleted cells were washed once in TSB and resuspended in fresh TSB (25 ml) to an OD 600 of 0.5. To measure changes in OM integrity, a 1-ml aliquot of the cell suspension was placed into a cuvette, and the baseline fluorescence was measured using excitation and emission wavelengths of 350 nm and 420 nm, respectively. Membrane integrity was then determined by utilizing N-phenyl-1-naphthylamine (NPN) (Sigma) as described previously, using a SpectraMax M5 fluorescence spectrophotometer (22, 38) . Changes in IM integrity were determined using similarly prepared cultures by measuring ATP leakage with the CellTiter-Glo luminescent kit (Promega) as described previously (39) . Membrane integrity was also assessed by using the Sytox orange (Molecular Probes) DNA stain (40, 41) . After growth to an OD 600 of 0.5 as described above, cells were resuspended in 25 ml of fresh TSB, and 2-ml samples were assayed. For fluorescence staining, a Sytox orange solution (50 M stock concentration) was added to the 2-ml culture to a final concentration of 500 nM. After 15 min of incubation in the dark, the cells were centrifuged once at 8,000 ϫ g for 10 min and resuspended in 2 ml of fresh TSB, and the cell OD 600 values were recorded. A 1-ml aliquot of the cell suspension was placed into a quartz spectrophotometer cuvette, and the fluorescence was measured by using excitation and emission wavelengths of 547 nm and 570 nm, respectively, with fluorescence measurement values normalized to the OD 600 . A two-tailed Student t test was used for all statistical analyses.
Liquid chromatography-mass spectrometry (LCMS) detection of lipid A precursors. Reversed-phase liquid chromatography (LC) coupled with multiple-reaction monitoring (MRM) of the lipid A biosynthetic intermediates in A. baumannii was performed by using an Agilent 1200 LC system interfaced with a 4000 Q-Trap hybrid triple-quadrupole linear ion trap mass spectrometer. A Phenomenex CN or C 8 column (5 m; 50 by 2.1 mm) was used for reversed-phase LC. The cell cultures were prepared according to the membrane permeability assay methods described above. A 5-ml cell sample at an OD 600 of 0.5 was pelleted, and protein was precipitated in 150 l SoluLyse protein extraction reagent (GenLantis). One hundred microliters of the supernatant was aliquoted into a 96-well plate (glass coat, 7-mm U base; Thermo Scientific), and 10 l was injected onto the reversed-phase column for LC-MRM analysis. Mobile phase A consisted of 10 mM aqueous ammonium acetate, and mobile phase B consisted of ethanol-isopropanol-acetone (50:25:25, vol/vol/vol). The following elution program was used: 100% mobile phase A was held isocratically for 1 min and then linearly increased to 100% mobile phase B at 4 min and held at 100% mobile phase B for 0.5 min. The LC gradient was then returned to 100% mobile phase A at 4.75 min and held at 100% mobile phase A for 8 min. The total LC flow rate was 500 l/min. MRM was performed in the negative-ion mode with the following Turbo V electrospray ionization (ESI) source mass spectrometry (MS) settings: 20 lb/in 2 curtain gas, 40 lb/in 2 ion source gas 1, 40 lb/in 2 ion source gas 2, ion spray voltage of Ϫ4,500 V, heater temperature of 550°C, interface heater on, declustering potential of Ϫ100 V, entrance potential of Ϫ10 V, and collision cell exit potential of Ϫ5 V. The MRM pairs for lipid IV A are m/z 1,319.9/79, 659.4/215, and 659.4/79, using collision energies of Ϫ130V, Ϫ50V, and Ϫ50V, respectively. The elution time for lipid IV A was between 5.7 and 5.8 min (see Table S2 in the supplemental material). Peak areas were normalized to the two blank mobile phase samples between each cell extract sample. The relative signal of lipid IV A was determined by using the sum of the predicted precursor/product ion pairs listed above. The MRM pairs, collision energies, and retention times for the lipid IV A precursors are listed in Table S2 (21) . We assayed only the most abundant isobaric lipid IV A and disaccharide 1-monophosphate (DSMP) species by MS. These species have three R-3-OH-C 12 acyl chains and one R-3-OH-C 14 acyl chain, and the specific location(s) of the single R-3-OH-C 14 chains was not determined in this study. We assayed only UDP-2,3-diacyl-GlcN with two R-3-OH-C 12 acyl chains and lipid X with one R-3-OH-C 12 acyl chain and one R-3-OH-C 14 acyl chain. An example structure for lipid IV A is shown in Fig. 4 , and example structures for the other precursors are shown in Fig. S5 in the supplemental material. E. coli lipid IV A was used for the generation of standard curves (Cymit Quimica), and a P. aeruginosa LpxC substrate was used as an internal standard where indicated (35) . A two-tailed Student t test was used for statistical analysis.
Thin-section transmission electron microscopy. Cultures grown overnight were diluted in TSB to an OD 600 of 0.01 and grown for 4 to 5 h to an optical density of 0.5. One milliliter of cell culture was harvested by centrifugation at 4,000 ϫ g for 10 min at room temperature. Cell pellets were suspended in Tousimis fixative (1.5% glutaraldehyde-1% formic acid in 0.12 M Sorensen's buffer) from Tousimis Research Corporation and submitted to the University of California, Davis, Center for Biophotonics Science and Technology (Sacramento, CA, USA) for embedding and thin-section preparations.
RESULTS
A. baumannii ATCC 19606 can tolerate loss of LptD. Given recent reports that some A. baumannii strains can tolerate the loss of LPS biosynthesis, we asked whether this organism could tolerate the loss of LPS transport to the OM. The genetic inactivation of the lptD gene encoding the final translocase required to assemble LPS into the outer leaflet of the OM confirmed that A. baumannii ATCC 19606 can indeed survive in the absence of final LPS transport, despite the presence of the upstream machinery required to synthesize LPS. We also inactivated lpxC to generate the strain lacking biosynthesis of LPS, confirming here that LPS biosynthesis is not required for survival under our growth conditions. In contrast, neither mutant grew on MacConkey agar, reflecting membrane permeability defects. Complementation of the mutants in trans restored growth on MacConkey agar, indicating restoration of the permeability barrier (see Fig. S1A in the supplemental material) .
Loss of lptD reduces LPS levels and decreases susceptibility to polymyxin B. Since A. baumannii ATCC 19606 could tolerate the loss of the final step in LPS assembly into the OM, despite the presence of intact LPS biosynthetic machinery, we next assessed the amount of cell-associated LPS present in the lptD::Km r mutant. The lptD::Km r mutant produced LPS, consistent with the presence of intact LPS biosynthesis, albeit at lower levels than those of the ATCC 19606 parent (Fig. 1A) , similar to previously reported observations for a Neisseria meningitides imp mutant (42) . As expected, no LPS was detected in the lpxC::Km r mutant (LPS negative control). Whether the lower levels of LPS seen for the lptD::Km r mutant reflect downregulation of LPS biosynthesis or shedding of LPS into the medium in the absence of proper LPS transport remains to be determined. Due to the loss of LPS, the lpxC::Km r mutant was highly resistant to colistin (Fig. 1B) , as previously reported (22) . The lptD::Km r mutant was less susceptible to polymyxin B than the ATCC 19606 parent, presumably reflecting the observed reduction in the amount of cell-associated and/or surfaced-exposed LPS (Fig. 1B) . Complementation of either mutation in trans restored sensitivity to polymyxin B and the production of normal levels of cell-associated LPS (see Table S1 and various growth and medium conditions (Fig. 2) . In MHIIB and TSB, growth of the lptD::Km r mutant was characterized by an extended lag phase, decreased growth rate, and low cell density at stationary phase compared to those of A. baumannii ATCC 19606. Similar growth defects were also observed for the lpxC::Km r mutant ( Fig. 2 ; see also Fig. S2 in the supplemental material) . Complementation of the mutants in trans restored growth defects (see Fig. S1C in the supplemental material) .
Deletion of lptD increases OM permeability and hypersensitivity to hydrophobic antibiotics more than does deletion of lpxC. The loss of LPS in A. baumannii was previously shown to increase susceptibility to a range of antibiotics (22) . We also observed increased susceptibility to a subset of hydrophobic antibiotics in the lpxC::Km r mutant, but the loss of lptD had an even more profound effect on susceptibility (Table 1; see also Table S1 in the supplemental material). This suggested that membrane integrity is more compromised by the loss of LPS assembly into the OM than by the complete loss of LPS synthesis. To examine this further, the OM integrities of the lpxC::Km r mutant and the lptD:: Km r mutant were compared by using the probe NPN. This probe has higher fluorescence in hydrophobic environments (e.g., in membranes) and has been used to measure envelope integrity (22, 38) . NPN fluorescence was higher in both the lpxC::Km r mutant and the lptD::Km r mutant than in the parent strain, showing that both mutants had compromised membrane integrity. However, consistent with the antibiotic susceptibility data described above, envelope integrity was more compromised by the loss of LptD than by the loss of LpxC, as measured by using this method (Fig.  3A) . Membrane permeability was also assessed by using an orthogonal assay employing the nucleic acid dye Sytox orange (Molecular Probes), with similar results (see Fig. S3A in the supplemental material).
Deletion of lptD disrupts the inner membrane more than does deletion of lpxC. Given the interrelationships between IM and OM synthesis and function, and the notion that detergentlike intermediates may accumulate upon disruption of certain steps in LPS biosynthesis or transport, we examined the impact of deleting lpxC or lpxD on IM integrity. Gross leakage of ATP, reflecting perturbation of the IM, was detected with the CellTiterGlo luminescence assay. Intriguingly, both mutants had some level of IM disruption according to this measure, but again, deletion of lptD had a larger impact on the cytoplasmic membrane than did deletion of lpxC ( Fig. 3B ; see also Fig. S4 in the supplemental material).
Disruption of LPS transport causes accumulation of lipid IV A .
It is reasonable to suspect that the disruption of downstream LPS biosynthetic or transport genes in general would allow more opportunities for the accumulation of upstream intermediates that interfere with membrane integrity and growth (28) . Since deletion of the gene encoding the terminal step in this process, lptD, indeed caused a more profound effect on the IM than did deletion of lpxC, there could be accumulation of an LPS pathway intermediate(s) mediating some or all of the observed phenotype. To examine this more directly, we measured the accumulation of intermediates related to the first six conserved enzymes in the Lpx pathway in the lptD::Km r mutant strain (21) . Targeted nificant change to any of the other monitored pathway intermediates ( Fig. 5 ; see also Table S2 in the supplemental material). Since we were monitoring only specific previously reported pathway intermediates, we would not have observed shifts in acyl chain profiles of lipid IV A or its precursors (21) . In E. coli, lipid IV A is normally glycosylated and further acylated before it is flipped across the inner membrane and then transported to the outer membrane (1, 43) . Since lipid IV A is normally present at low levels in wild-type (WT) cells, the accumulation and/or mislocalization of lipid IV A in the lptD::Km r mutant could impact membrane integrity; however, it remains to be determined if lipid IV A is specifically responsible for the IM effects observed here (44) (45) (46) (47) . Furthermore, although we focused on the first six steps of the pathway, we cannot rule out accumulation and/or mislocalization of other pathway intermediates, including more mature forms of LPS. In P. aeruginosa, disruption of LPS transport via depletion or inhibition of LptD or depletion of WaaP, an inner-core kinase required for efficient LPS transport to the OM, led to dramatic changes in membrane morphology and the accumulation of aberrant LPS (13, 48) . Although A. baumannii ATCC 19606 deleted Table S2 and Fig. S5 in the supplemental material.
for lptD had an increased amount of electron-dense intracellular granules, characteristic of a response to nutritional stringencies, environmental stresses, or defects in cell membrane formation and function (49) (50) (51) , no gross internal accumulation of membrane-like material or other obvious envelope defects were seen (Fig. 6) .
Chemical inhibition of LpxC in the lptD::Km r mutant partially restores membrane permeability and growth. The accumulation of lipid IV A in the lptD::Km r strain, as described above, supported the notion that interference with LPS transport caused the toxic accumulation and/or mislocalization of pathway intermediates, contributing to the observed growth and permeability defects. If this were occurring, then blocking or interfering with the synthesis of LPS intermediates should at least partially ameliorate these effects. The ability of A. baumannii ATCC 19606 to tolerate the complete loss of LPS synthesis provided an elegant means to examine whether the inhibition of early stages in the LPS pathway (e.g., upstream of lipid IV A ) could offset some of the defects associated with the loss of LptD. Treatment of the lptD:: Km r mutant with a well-characterized LpxC inhibitor (CHIR-090) (52) (53) (54) (55) in fact partially restored permeability and growth ( Fig. 7 ; see also Fig. S3B in the supplemental material), presumably reflecting a reduction in the synthesis of toxic pathway intermediates. Interestingly, the near-WT levels of ATP released from the lptD::Km r mutant treated with CHIR-090 suggest that intermediate accumulation affects primarily IM integrity (Fig. 7B) . As expected, no rescue was observed for the lpxC::Km r mutant upon exposure to CHIR-090, indicating that the rescue observed for the lptD::Km r mutant was the result of CHIR-090 inhibition of LpxC (on target). Furthermore, LPS gels confirmed that CHIR-090 treatment of A. baumannii ATCC 19606 (parent) caused a significant depletion of LPS, consistent with the specific inhibition of LPS biosynthesis under our test conditions (data not shown). Finally, antibiotics, including polymyxin B, ciprofloxacin, chloramphenicol, and vancomycin, were not able to restore the growth of the lptD::Km r mutant (data not shown). Inhibition of fatty acid biosynthesis partially restores growth and permeability of the lptD::Km r mutant. In E. coli, LPS transport disruption-induced lethality could be suppressed by the inhibition of fatty acid biosynthesis (32) . This rescue was attributed to a reduced rate of cell envelope growth facilitated by an increased doubling time and decreased cell size (32) . We show here that sublethal exposure to cerulenin, an irreversible inhibitor of ␤-ketoacyl-ACP synthases I and II (56-59) (FabB/H), could partially restore growth and improve the IM and OM integrity of the lptD::Km r mutant ( Fig. 8 ; see also Fig. S3B in the supplemental material).
DISCUSSION
LPS is a major component of the outer leaflet of the Gram-negative bacterial OM. LPS is essential for the growth of most Gramnegative organisms, and the OM provides an effective permeability barrier against toxic compounds, including many antibiotics (60) . Therefore, proteins involved in maintaining the permeability barrier, including those directly involved in LPS biosynthesis, may be attractive for the development of novel antibiotics for clinical use against Gram-negative pathogens alone or in combination. Also, it has been proposed that inhibition of certain steps of LPS biosynthesis could be more detrimental to cells by causing toxic accumulation of pathway intermediates that may disrupt IM or OM function/integrity (28, 29) . Interference with LptD-mediated LPS translocation in P. aeruginosa caused aberrant membrane-like material to accumulate within the periplasm (13) . Similarly, depletion of WaaP, an essential kinase required for LPS core synthesis, caused the accumulation of truncated LPS in the IM, attributed to an inability to transport this aberrant LPS to the OM (48) .
The ability of A. baumannii ATCC 19606 to survive in the absence of LPS synthesis allowed us to examine this concept more specifically. We confirmed that lpxC could be deleted in this strain, as previously reported (22, 61) , and extended this by demonstrating that lptD could also be genetically inactivated despite the presence of an intact LPS biosynthetic pathway. Cells lacking lpxC, and therefore lacking LPS entirely, were highly resistant to polymyxin B, as expected (22) . The loss of lptD caused a significant decrease in the amount of cell-associated LPS and a concomitant decrease in susceptibility to polymyxin B. The lptD::Km r mutant exhibited growth defects similar to those of the lpxC::Km r mutant but, surprisingly, had comparatively lower IM and OM integrity, which presumably mediated increased susceptibility to hydrophobic an- tibiotics relative to the lpxC::Km r mutant. Since LptD mediates the distal transport of mature LPS, its absence should cause some accumulation of varied forms of LPS in the membrane(s), since the machinery to synthesize intact LPS is present in lptD::Km r mutant cells. However, electron microscopy did not reveal any gross membrane defects in the lptD::Km r mutant like those described previously for P. aeruginosa upon interference with LPS transport (13, 14, 48) . Since A. baumannii ATCC 19606 tolerates the absence of LptD and can apparently compensate somewhat for the lack of normal LPS transport, this defect itself may not be expected to manifest such pronounced morphological changes. It is not clear how A. baumannii ATCC 19606 offsets the membrane accumulation in the periplasm typical of certain other LptD-defective mutants, but this could involve a downregulation of LPS biosynthesis, although we did not see any reduction in early-stage LPS metabolite levels in the lptD::Km r mutant (42) . Additional possibilities include the shedding of LPS into the medium or some LPS translocation to the OM surface by a less efficient LptD-independent pathway. Despite the lack of obvious membrane accumulation, mislocalization of smaller amounts of LPS in the membrane(s) could still be affecting envelope integrity. Although the exact identity of the pathway intermediates that may be affecting membrane integrity has not been definitely demonstrated, the observation that the inhibition of LPS biosynthesis with an LpxC inhibitor partially reversed the growth and membrane defects of the lptD::Km r mutant clearly supports the idea that such an accumulation and/or mislocalization is involved in the resulting envelope and growth phenotypes. In the case of cerulenin, it is unclear whether the partial rescue of growth and permeability was due to a lower level of lipid A biosynthesis caused by a reduced availability of acyl chain donors (consequently alleviating toxic LPS-associated intermediates) or, alternatively, a restoration of phospholipid and LPS biosynthesis homeostasis to shift toward wild-type permeable cells, as observed in E. coli (31, 32) . Chemical inhibition of LpxC or FabB/F did not fully restore the lptD::Km r mutant's permeability barrier to wild type, perhaps indicating that factors other than modulating the balance between LPS and phospholipid play a role in these phenomena in A. baumannii, but this remains to be further explored.
Taken together, our data suggest that blocking of LPS assembly in A. baumannii ATCC 19606 leads to an accumulation and/or mislocalization of membrane intermediates disrupting membrane integrity and growth that can be partially rescued through inhibition of lipid A biosynthetic enzymes or components of phospholipid biosynthesis (e.g., fatty acid). This highlights how the inhibition of a given antibacterial target may affect cells by multiple mechanisms but also that targeting LPS biosynthesis/ transport at multiple steps or different pathways by combinations of agents could lead to some level of antagonism, with one agent partially offsetting the activity of the other.
